Diabetes Mellitus (DM) disrupts the body's capability to control blood glucose statuses. Type 1 diabetes mellitus (T1DM) arises from inadequate insulin production and is treated with insulin replacement therapy. Stem cell therapy is a hopeful treatment for T1DM that involves using adult stem cells to generate insulin-producing cells (IPCs). Mesenchymal stem cells (MSCs) are particularly advantageous for generating IPCs. The islet cells require interactions with the extracellular matrix for survival, which is lacking in conventional 2D culture systems. Natural or synthetic polymers create a supportive 3D microenvironment in tissue engineering. We aim to construct superior differentiation conditions employing polyethersulfone (PES)/Fish gelatin scaffolds to differentiate Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs) to IPCs. In this study, the PES/fish gelatin scaffold (3D) was manufactured by electrospinning, and then its biocompatibility and non-toxicity were investigated by MTT assay. After that, scaffold-supportive effects on WJ-MSCs differentiation to IPCs were studied at the gene and protein levels. After exposure to the differentiation media, 2D and 3D (PES/Fish gelatin) cultured cells were slowly aggregated and developed spherical-shaped clusters. The viability of cells was found to be comparable in both 2D and 3D cultures. The gene expression analysis showed that efficiency of differentiation was more elevated in 3D culture. Additionally, ELISA results indicated that C-peptide and insulin release were more significant in 3D than in 2D culture. In conclusion, the PES/fish gelatin scaffold is highly promising for pancreatic tissue engineering because it supports the viability, growth, and differentiation of WJ-MSCs into IPCs.
Mushroom-derived products are increasingly recognized as promising immunomodulatory therapeutics. This study aimed to evaluate the immunomodulatory properties of polysaccharides and characterize secondary metabolites from Trametes hirsuta (Wulfen) Lloyd. Sterol derivatives were isolated using column chromatography, while polysaccharides were obtained via hot water extraction, purified by ethanol precipitation, and dialyzed. Polysaccharide content was measured with the phenol-sulfuric acid method. Antioxidant activity was assessed using DPPH and FRAP assays. The volatile fraction was obtained by hydrodistillation and analyzed by GC-MS Spectrometry. The total phenolic content was determined by the Folin-Ciocalteu method. The cytotoxicity of the polysaccharide fraction on THP-1 cells was evaluated using the XTT assay in 2D and 3D cultures and its effects on IL-1β and TNF-α secretion were assessed. Identified compounds included ergosterol, ergosterol peroxide and ergosteryl acetate, and the phenolic compound 3,2,6-di-tert-butyl-4-(hydroxymethyl) benzoic acid, which was identified for the first time in T. hirsuta. The polysaccharide content was quantified at 53.10 ± 2.87%. Cytotoxicity testing showed non-toxic doses of 10 and 240 μg/mL in 2D cultures, and 10 and 670 μg/mL in 3D cultures. Using these concentrations, the extract induced a dose-dependent increase in IL-1β and TNF-α secretion. Total phenolic content of the methanol extract was 41.64 ± 3.81 mg gallic acid equivalent per gram of dry weight. The essential oil was rich in alcohols (19.64%) and aldehydes (16.43%). The methanol extract exhibited the highest antioxidant activity in FRAP assay (408.1667±0.1116 mmol Fe2+/gram dry weight). These findings support the immunomodulatory activity of T. hirsuta polysaccharides and warrant further investigation of their underlying receptor-mediated mechanisms.